🇫🇷
France · FR · FR:67194402
GAVRETO 100 mg, gélule
ATC L01EX23
Last synced from Base de données publique des médicaments — BDPM (France) on
Identification
ManufacturerBLUEPRINT MEDICINES (PAYS-BAS))
CountryFR (France)
ATC codeL01EX23
Dispensing—
ReimbursedNo
SourceBase de données publique des médicaments — BDPM (France)
Last synced6/3/2026
Packs · 1
- cip1334009302414481 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 60 gélule(s)
Annotations
No annotations yet.
Raw payload (JSON)
{
"cis": "67194402",
"date_amm": "2021-11-18",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/21/1555",
"statut_amm": "Autorisation abrogée",
"statut_bdm": "Warning disponibilité",
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Non commercialisée",
"surveillance_renforcee": "Oui"
}Related drugs
Other records sharing ATC code L01EX23.
- 🇺🇸GavretoGenentech, Inc.
- PLGavretoRoche Registration GmbH
- DKGavretoRoche Registration GmbH
- FIGavretoBlueprint Medicines Netherlands B.V.
- NOGavretoRoche
- 🇺🇸GavretoRigel Pharmaceuticals, Inc.
- BEGavreto 100 mgBlueprint Medicines (Netherlands)
- 🇪🇸GAVRETO 100 MG CAPSULAS DURASBlueprint Medicines (Netherlands) B.V.
Access this data programmatically
Query GAVRETO 100 mg, gélule and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.